{"id":49661,"date":"2022-10-14T19:01:53","date_gmt":"2022-10-14T17:01:53","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/synthetic-biology-global-market-report-2022-robotics-and-workflow-automation-support-market-expansion-researchandmarkets-com\/"},"modified":"2022-10-14T19:01:53","modified_gmt":"2022-10-14T17:01:53","slug":"synthetic-biology-global-market-report-2022-robotics-and-workflow-automation-support-market-expansion-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/synthetic-biology-global-market-report-2022-robotics-and-workflow-automation-support-market-expansion-researchandmarkets-com\/","title":{"rendered":"Synthetic Biology Global Market Report 2022: Robotics and Workflow Automation Support Market Expansion – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Synthetic Biology – Global Market Trajectory & Analytics”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nGlobal Synthetic Biology Market to Reach $36 Billion by 2027<\/strong>\n<\/p>\n

\nIn the changed post COVID-19 business landscape, the global market for Synthetic Biology estimated at US$6.4 Billion in the year 2020, is projected to reach a revised size of US$36 Billion by 2027, growing at a CAGR of 28.1% over the analysis period 2020-2027. Oligonucleotides & Synthetic DNA, one of the segments analyzed in the report, is projected to record a 29.5% CAGR and reach US$16.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Enzymes segment is readjusted to a revised 27% CAGR for the next 7-year period.\n<\/p>\n

\nThe U.S. Market is Estimated at $2.5 Billion, While China is Forecast to Grow at 32.4% CAGR<\/strong>\n<\/p>\n

\nThe Synthetic Biology market in the U.S. is estimated at US$2.5 Billion in the year 2020. China, the world’s second largest economy, is forecast to reach a projected market size of US$3.8 Billion by the year 2027 trailing a CAGR of 32.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 26.3% and 27.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 29.3% CAGR.\n<\/p>\n

\nCloning Technology Kits Segment to Record 26.8% CAGR<\/strong>\n<\/p>\n

\nIn the global Cloning Technology Kits segment, USA, Canada, Japan, China and Europe will drive the 26.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$939.9 Million in the year 2020 will reach a projected size of US$4.9 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.\n<\/p>\n

\nSelect Competitors (Total 141 Featured) –<\/strong>\n<\/p>\n